**Core Concept:** Beta blockers are a class of drugs that modulate the effects of adrenaline on beta receptors, primarily in the heart and blood vessels. They are used in the management of various cardiovascular conditions, primarily due to their anti-ischemic and antiarrhythmic properties.

**Why the Correct Answer is Right:** Beta blockers are classified into three types based on their selectivity for beta1 (cardiac) or beta2 (non-cardiac) receptors:
1. Selective beta1 blockers: These drugs selectively bind to beta1 receptors, which are predominantly found in the heart. Examples include atenolol, bisoprolol, and metoprolol.
2. Selective beta2 blockers: These drugs primarily bind to beta2 receptors, which are found in the bronchioles and smooth muscles. Examples include salbutamol and terbutaline.
3. Non-selective beta blockers: These drugs bind to both beta1 and beta2 receptors, but with a higher affinity for beta1 receptors. Examples include propranolol, acebutolol, and nadolol.

**Why Each Wrong Option is Incorrect:**
1. A. Selective beta2 blockers: Although these drugs have beta2 blocking properties, they also possess significant beta1 blocking properties, making them incorrect as a standalone classification.
2. B. Non-selective beta blockers: These drugs do bind to both beta1 and beta2 receptors with equal affinity, but the correct classification includes their relative preference for beta1 receptors.
3. C. Selective beta2 blockers: As mentioned above, these drugs have significant beta1 blocking properties as well, making this classification incorrect.
4. D. Non-selective beta blockers: As mentioned above, this classification includes the relative preference for beta1 receptors, making it correct.

**Clinical Pearl:** Beta blockers are often classified into two groups based on their selectivity: beta1-selective and beta2-selective. These classifications are crucial for understanding their pharmacodynamics and selecting the appropriate drug for specific clinical conditions. For example, beta1-selective drugs are preferred for treating angina pectoris, while beta2-selective drugs are used for asthma treatment. Understanding the pharmacodynamics of beta blockers helps in selecting the right medication for the right indication, ensuring patient safety and optimal treatment outcomes.